Hoppe George, Bolok Youstina, McCollum Leah, Zhang Jin, Sears Jonathan E
Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Front Cell Dev Biol. 2020 Jun 23;8:488. doi: 10.3389/fcell.2020.00488. eCollection 2020.
Here we rank order small molecule inhibitors of hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs) using severity of oxygen induced retinopathy (OIR) as an outcome measure. Dose response analyses in cell cultures of hepatoma (Hep3B), retinal Müller cells (MIO-M1) and primary retinal endothelial cells were conducted to evaluate potency by comparing dose to HIF-1,2 protein levels by western blotting. dose response was determined using the luciferase-transgene HIF reporter (luc-ODD). Each compound was placed in rank order by their ability to reduce neovascularization and capillary drop out in the OIR mouse model. An KO confined to retinal Müller cells was used to determine whether successful protection by HIF stabilization requires HIF-2. Two candidate small molecules can prevent OIR by stabilizing HIF-1 to prevent oxygen induced growth attenuation and vascular obliteration. Müller cell HIF-2, the mediator of pathologic retinal angiogenesis, is not required for protection. The lack of dependence on Müller cell HIF-2 predicts that inhibition of HIF PHD will not drive pathological angiogenesis.
在此,我们以氧诱导性视网膜病变(OIR)的严重程度作为结果指标,对缺氧诱导因子(HIF)脯氨酰羟化酶(PHD)的小分子抑制剂进行排序。在肝癌细胞(Hep3B)、视网膜穆勒细胞(MIO-M1)和原代视网膜内皮细胞的细胞培养物中进行剂量反应分析,通过蛋白质印迹法比较剂量与HIF-1、2蛋白水平来评估效力。使用荧光素酶转基因HIF报告基因(luc-ODD)确定剂量反应。根据每种化合物在OIR小鼠模型中减少新生血管形成和毛细血管缺失的能力进行排序。使用仅限于视网膜穆勒细胞的基因敲除来确定通过HIF稳定化实现的成功保护是否需要HIF-2。两种候选小分子可通过稳定HIF-1来预防OIR,以防止氧诱导的生长衰减和血管闭塞。保护作用并不需要作为病理性视网膜血管生成介质的穆勒细胞HIF-2。对穆勒细胞HIF-2的不依赖表明,抑制HIF PHD不会引发病理性血管生成。